Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Chemotherapy Overuse May Be Encouraged By Medicare AWP System - Tauzin

Executive Summary

The Medicare drug reimbursement system may be encouraging oncologists to overuse chemotherapy in terminal patients, House Commerce Committee Chairman Billy Tauzin (R-La.) asserted Sept. 21.

You may also be interested in...



PhRMA CEO Tauzin Takes Over Jan. 3: PR Focus Begins At The Top

PhRMA's new management team under CEO Billy Tauzin will place a high priority on communications and partnerships with other stakeholders in healthcare policy debates

Oncology Rx Pricing Focus Shifts To Medicaid: House Cmte. Seeks Documents

The passage of AWP reform in Medicare will not end Congressional scrutiny of the oncologic drug market

Oncology Rx Pricing Focus Shifts To Medicaid: House Cmte. Seeks Documents

The passage of AWP reform in Medicare will not end Congressional scrutiny of the oncologic drug market

Related Content

UsernamePublicRestriction

Register

PS038575

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel